EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Innovative Probiotic-Based Supplement to Mitigate Molecular Factors Connected to Depression and Anxiety: An In Vitro Study

Sara Ferrari, Simone Mulè, Giorgia Rosso, Francesca Parini, Rebecca Galla, Claudio Molinari, Francesca Uberti

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sara Ferrari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiology, Department for Sustainable Development and Ecological Transition, 13100 Vercelli, Italy. Hauptthemen laut MEDLINE: Probiotics, Anxiety, Depression, Gastrointestinal Microbiome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut–brain axis is a bidirectional relationship between the microbiota and the brain; genes related to the brain and gut synaptic formation are similar. Research on the causal effects of gut microbiota on human behavior, brain development, and function, as well as the underlying molecular processes, has emerged in recent decades. Probiotics have been shown in several trials to help reduce anxiety and depressive symptoms. Because of this, probiotic combinations have been tested in in vitro models to see whether they might modulate the gut and alleviate depression and anxiety. Therefore, we sought to determine whether a novel formulation might affect the pathways controlling anxiety and depression states and alter gut barrier activities in a 3D model without having harmful side effects. Our findings indicate that B. bifidum novaBBF7 10 mg/mL, B. longum novaBLG2 5 mg/mL, and L. paracasei TJB8 10 mg/mL may influence the intestinal barrier and enhance the synthesis of short-chain fatty acids. Additionally, the probiotics studied did not cause neuronal damage and, in combination, exert a protective effect against the condition of anxiety and depression triggered by L-Glutamate. All these findings show that probiotics can affect gut function to alter the pathways underlying anxiety and depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsAnxietyDepressionGastrointestinal MicrobiomeHumansBrain-Gut AxisDietary Supplements

Stichwörter der Autor:innen

combined effectgut–brain axisin vitro studymental disorderoral probiotic formulation

Autor:innen und Institutionen

  • Laboratory of Physiology, Department for Sustainable Development and Ecological Transition, 13100 Vercelli, Italy.
  • Noivita Srls, Spin Off of the University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.

Zitieren

APA

Ferrari, S., Mulè, S., Rosso, G., Parini, F., Galla, R., Molinari, C., & Uberti, F. (2024). An Innovative Probiotic-Based Supplement to Mitigate Molecular Factors Connected to Depression and Anxiety: An In Vitro Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094774

Vancouver

Ferrari S, Mulè S, Rosso G, Parini F, Galla R, Molinari C, et al. An Innovative Probiotic-Based Supplement to Mitigate Molecular Factors Connected to Depression and Anxiety: An In Vitro Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094774

BibTeX
@article{Ferrari2024,
  author = {Ferrari, Sara and Mulè, Simone and Rosso, Giorgia and Parini, Francesca and Galla, Rebecca and Molinari, Claudio and Uberti, Francesca},
  title = {An Innovative Probiotic-Based Supplement to Mitigate Molecular Factors Connected to Depression and Anxiety: An In Vitro Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094774}
}
Kostenlos starten →